# Phase A Current-State Reconciliation — 2026-08-14 post-PR38

> Dated control-plane reconciliation after PR #38 merge
>
> Exact Enterprise Base: `6ee86cb001aceb8a6cf264c9a6fbd629dddd8dda`
>
> Purpose: record **current** control truth after PR #38 without rewriting
> historical planning rows, PR #29 body, P7 evidence,
> `phase-a-current-state-addendum.md`, or the pre-merge
> [2026-08-14 reconciliation](./phase-a-current-state-reconciliation-2026-08-14.md)
>
> Related artifacts:
> [a6-5-legacy-clinical-non-adoption-strategy.md](./a6-5/a6-5-legacy-clinical-non-adoption-strategy.md)
> [a6-5-e01-disposition-board.csv](./a6-5/a6-5-e01-disposition-board.csv)
> [a6-5-e01-disposition-board-report.md](../../evidence/phase-a/a6-5/a6-5-e01-disposition-board-report.md)

## 1. Interpretation

The earlier 2026-08-14 note remains a **pre-merge** snapshot
(`IMPLEMENTED_PENDING_INDEPENDENT_REVIEW` for PR #38 planning).
This dated note supersedes **current-control pointers only**.

```text
Do not rewrite PR #29 historical authority
Do not rewrite P7 evidence
Do not rewrite historical addendum semantics
Do not rewrite old merge SHAs
```

## 2. Enterprise current truth (until this E01 PR merges)

```text
PR #38: MERGED
Merge SHA: 6ee86cb001aceb8a6cf264c9a6fbd629dddd8dda
Parent 1: 49b0e4467fb4cf96a4893f9158bf23584ab69ee5
Parent 2: 1f49e5b7f9bc48ec88ae900c7f3e012a33fe3f88

A6.5-NONADOPT-001: MERGED_AND_VERIFIED
Legacy Clinical: NON_ADOPTED
Owner Decision: LEGACY_CLINICAL_ASSETS_WILL_NOT_BE_MIGRATED

B04: SUPERSEDED_BY_LEGACY_CLINICAL_NON_ADOPTION
     NOT_REQUIRED_FOR_NEW_RUNTIME_MIGRATION
     Executed: NO
     Machine status: BLOCKED (existing enum; not EXECUTED_COMPLETE)

C02: NOT_REQUIRED_FOR_REJECTED_ASSETS
     Executed: NO
     Machine status: BLOCKED (existing enum; not EXECUTED_COMPLETE)

E01: AUTHORIZED_BY_OWNER_TASK (this E01 branch)
     Branch implementation: IMPLEMENTED_PENDING_INDEPENDENT_REVIEW
     Machine backlog status: PLANNED (existing enum; no illegal status invented)
     Not: MERGED_AND_VERIFIED
     Not: COMPLETE_AND_EXITED

E02: NOT_AUTHORIZED
     Executed: NO
     Final matrix write-back: 0

A6.5: INCOMPLETE_PENDING_E01_E02_EXIT
      Not: COMPLETE
      Not: EXIT PASSED

PHASE_A_NC_CLOSURE_ROADMAP_AMENDMENT: MERGED_AND_VERIFIED
PHASE_A_NC_CLOSURE implementation: NOT_AUTHORIZED
NC-CLOSE-01: NOT_AUTHORIZED
A8 / A9 / A10 / A11: NOT_AUTHORIZED

A7-NC: COMPLETE
A7-NC Exit: PASSED
A7-CL: BLOCKED
A7: NOT_COMPLETE
FUTURE_NEW_CLINICAL_TRACK: NOT_AUTHORIZED

Clinical Runtime: NOT_ENABLED
Production: BLOCKED
Phase B: NOT_AUTHORIZED

Architecture Change: NO
Architecture Refreeze: NOT_REQUIRED
CI: NO_CI_CONFIGURED
Real Provider: FORBIDDEN
```

## 3. E01 branch proposed truth (not Enterprise official until IR + merge)

Branch: `agent/a6-5-e01-disposition-board`

```text
TASK-E01: IMPLEMENTED_PENDING_INDEPENDENT_REVIEW
Population: inventory UNION(P0/P1 + remaining clinical-logic + justified boundary)
Historical TASK-E01.asset_ids (40): HISTORICAL_SEED_SET only
Authoritative board: a6-5-e01-disposition-board.csv
Decommission register: legacy-asset-decommission-register.csv
Physical deletion: NOT_AUTHORIZED / 0
E02: NOT_EXECUTED
```

## 4. Capability truth (unchanged)

```text
adult_respiratory_v1:
  DRAFT
  PARTIALLY_VALIDATED
  REQUIRES_CLINICAL_REVIEW
  NOT_IMPLEMENTED
  Production Eligibility: BLOCKED
  approved rules / thresholds / hypotheses / sources: 0
```

BOUND-002 (`capabilities/adult_respiratory_v1`) is `NEW_A6_BOUNDARY` /
`NOT_LEGACY_RETENTION_SUBJECT`. A6 lifecycle is unchanged.

## 5. Semantic assertions

```text
A7-NC COMPLETE != A7 COMPLETE
NON_ADOPTION MERGED != A6.5 COMPLETE
E01 BOARD RECORDED != E02 COMPLETE
FUTURE_REBUILD_REQUIRED != START NEW CLINICAL NOW
PHASE_A_NC_CLOSURE_ROADMAP_AMENDMENT MERGED != NC CLOSURE AUTHORIZED
A11 eligibility != A11 PASS
```

## 6. Historical order

```text
A1 → A2 → A3 → A4 → A5 → A6 → A6.5 → A7 → A8 → A9 → A10 → A11
```

Preserved. Recommended remaining A6.5 path:

```text
E01 Independent Review → E02 (separate authorization) → A6.5 Exit
```

## 7. Next Gate

```text
A6.5-E01 Disposition Board Independent Review
for exact Draft PR Head on agent/a6-5-e01-disposition-board
```

Do not execute Independent Review from this note.
Do not mark Ready, Merge Review, or merge from this note.
Do not authorize E02, A6.5 Exit, NC-CLOSE-01, A8–A11, A7-CL,
new clinical content, or Phase B from this note.
